[ Fri, Nov 07th 2025 ]: Knoxville News Sentinel
Oak Ridge football 'disappointed' after being upset by Science Hill in TSSAA playoffs
[ Thu, Nov 06th 2025 ]: ABC Kcrg 9
New 911 Emergency Communication Center delivers dispatchers space, technology upgrades
[ Thu, Nov 06th 2025 ]: Sports Illustrated
[ Thu, Nov 06th 2025 ]: Los Angeles Times
Wall Street loses ground under the weight of falling technology stocks
[ Thu, Nov 06th 2025 ]: Wyoming News
[ Thu, Nov 06th 2025 ]: rnz
Infectious disease research gets $75 million funding boost from government
[ Thu, Nov 06th 2025 ]: Chicago Tribune
Art Institute announces $50 million conservation center, with the public welcome to watch the work
[ Thu, Nov 06th 2025 ]: BBC
[ Thu, Nov 06th 2025 ]: Time
[ Thu, Nov 06th 2025 ]: legit
"Ignore any question on Trump": Akpabio cautions Tinubu's new minister
[ Thu, Nov 06th 2025 ]: The Independent US
How a woman's journey with lupus reflects science's way of tackling the disease
[ Thu, Nov 06th 2025 ]: 19 Action News
[ Thu, Nov 06th 2025 ]: USA Today
This author keeps predicting new 'dystopian' AI technology. What will come true next?
[ Thu, Nov 06th 2025 ]: Fortune
Mark Zuckerberg, Priscilla Chan shift philanthropy focus to how AI can accelerate science | Fortune
[ Thu, Nov 06th 2025 ]: WGME
NY Man convicted for stealing US Technology and pitching it's military use to China
[ Thu, Nov 06th 2025 ]: Cleveland.com
Security technology company to shutter Twinsburg facility, cut 240 jobs
[ Thu, Nov 06th 2025 ]: Fox 11 News
NY man convicted for stealing US technology and pitching its military use to China
[ Thu, Nov 06th 2025 ]: The Scotsman
Think biowearable technology is just for athletes? Think again (aff)
[ Thu, Nov 06th 2025 ]: Los Angeles Daily News
Why Neil deGrasse Tyson says we're falling into science illiteracy
[ Thu, Nov 06th 2025 ]: WSB-TV
Zuckerberg, Chan shift bulk of philanthropy to science, focusing on AI and biology to curb disease
[ Thu, Nov 06th 2025 ]: The Motley Fool
Array Technologies (ARRY) Q3 2025 Earnings Call Transcript | The Motley Fool
[ Thu, Nov 06th 2025 ]: RTE Online
[ Thu, Nov 06th 2025 ]: Searchenginejournal.com
Deploying Agentic AI For SEO: A Playbook For Technology Leaders
[ Thu, Nov 06th 2025 ]: 24/7 Wall St
Is Bitmine Immersion Technologies (BMNR) Stock at $100 a Pipe Dream?
[ Thu, Nov 06th 2025 ]: Impacts
The Science Behind Dust: How Technology is Helping Decode the Hidden Health Risks in Our Homes
[ Thu, Nov 06th 2025 ]: National Geographic news
[ Thu, Nov 06th 2025 ]: wtvr
Start your career in business & information technology at Bryant & Stratton College
[ Thu, Nov 06th 2025 ]: lex18
Alltech breaks ground on new crop science facility in Nicholasville
[ Thu, Nov 06th 2025 ]: Digit
Kosmos explained: The AI scientist that can read 1,500 papers
[ Thu, Nov 06th 2025 ]: moneycontrol.com
Science behind why humans stopped sleeping twice every night
[ Thu, Nov 06th 2025 ]: Seeking Alpha
Janus Henderson Global Life Sciences Fund Q3 2025 Portfolio Update
[ Thu, Nov 06th 2025 ]: News 12 Networks
Manhattan University political science professor on the impact of the NYC mayoral election
[ Wed, Nov 05th 2025 ]: Fox 11 News
Neville Public Museum hopes to inspire curiosity with new Children's Discovery Room
[ Wed, Nov 05th 2025 ]: NJ.com
No. 19 Madison blanks Science Park in North 2, Group 2 first round - Girls soccer recap
[ Wed, Nov 05th 2025 ]: Boston.com
Education technology company to close Boston headquarters, embrace fully remote workplace
[ Wed, Nov 05th 2025 ]: WLWT
Cincinnati prepares for snow removal season with new technology, training
[ Wed, Nov 05th 2025 ]: Dallas Morning News
Texas Christian University receives $40 million gift to bolster science, engineering research
[ Wed, Nov 05th 2025 ]: The Times of Northwest Indiana
Natural Remedies That Actually Work: A Science-Backed Guide to Herbal Alternatives
[ Wed, Nov 05th 2025 ]: Investopedia
Top Stock Movers Now: Seagate Technology, McDonald's, Trex, Pinterest, and More
[ Wed, Nov 05th 2025 ]: Houston Public Media
[ Wed, Nov 05th 2025 ]: Variety
[ Wed, Nov 05th 2025 ]: Seeking Alpha
Opendoor Technologies Q3 2025 Earnings Preview (OPEN:NASDAQ)
[ Wed, Nov 05th 2025 ]: BroBible
[ Wed, Nov 05th 2025 ]: Toronto Star
[ Wed, Nov 05th 2025 ]: Forbes
The Role Of Technology And Innovation In The Future Of Medicaid
[ Wed, Nov 05th 2025 ]: WLOX
[ Wed, Nov 05th 2025 ]: dw
China is the new science power: How will Europe respond? - DW - 11/05/2025
[ Wed, Nov 05th 2025 ]: The Center Square
Janus Henderson Global Life Sciences Fund Q3 2025 Portfolio Update
Seeking Alpha
Sarepta Therapeutics (SRPT) – added for its AAV‑based gene therapy for Duchenne muscular dystrophy. Kiadis Pharma (KPTX) – brought in for its oncology cell‑therapy program targeting triple‑negative breast cancer. Exact Sciences (EXAS) – a diagnostic leader in colorectal cancer screening.
Conversely, the fund reduced exposure to Biogen (BIIB) by 2.1 percentage points, citing a slowdown in its mRNA vaccine pipeline and shifting emphasis toward newer, high‑growth biotech ventures.
Investment Thesis and Outlook
Janus Henderson’s manager emphasizes a forward‑looking investment thesis that hinges on the convergence of precision medicine, gene editing, and digital health. The firm believes that the integration of AI and genomics will accelerate drug discovery, reduce time‑to‑market, and lower development costs. The update cites the fund’s “dynamic allocation model” that allows rapid positioning in breakthrough technologies while maintaining a disciplined risk framework.
The fund’s risk management strategy remains anchored by a diversified geographic footprint. While 74.6 % of the portfolio is concentrated in North America and Europe, the fund still holds 11.2 % in emerging markets such as China and India, primarily in local biopharma and diagnostic companies.
Liquidity and Expense
Liquidity remains high, with a 3‑month turnover rate of 18.5 %. The fund’s expense ratio of 0.79 % aligns with its peers in the actively managed life‑sciences segment. Management notes that the lower expense ratio relative to index‑tracking funds translates into better risk‑adjusted returns.
Key Takeaways
- Strong Q3 performance – 12.4 % net return, outperforming the MSCI World Life Sciences Index.
- Increased biotech exposure – 62.8 % of the portfolio now in biotech, up 4.1 percentage points YoY.
- High‑growth focus – New positions in gene therapy (CRISPR Therapeutics, Sarepta), diagnostics (Exact Sciences), and cell therapy (Kiadis Pharma).
- Strategic divestment – Reduced stake in Biogen to free capital for higher‑potential opportunities.
- Forward‑looking thesis – Emphasis on precision medicine, AI integration, and digital diagnostics.
For investors and analysts interested in the full portfolio breakdown, Janus Henderson provides a downloadable PDF of the latest holdings list, which can be accessed from the firm’s official website (https://www.janushenderson.com/). The firm also offers a quarterly research note detailing the macro‑economic and regulatory environment impacting the life‑sciences sector.
Read the Full Seeking Alpha Article at:
https://seekingalpha.com/article/4838873-janus-henderson-global-life-sciences-fund-q3-2025-portfolio-update